Yusuf S - Search Results

1

Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy.

Lonn E, Yusuf S, Hoogwerf B, Pogue J, Yi Q, Zinman B, Bosch J, Dagenais G, Mann JF, Gerstein HC; HOPE Study; MICRO-HOPE Study. Lonn E, et al. Among authors: yusuf s. Diabetes Care. 2002 Nov;25(11):1919-27. doi: 10.2337/diacare.25.11.1919. Diabetes Care. 2002. PMID: 12401733 Clinical Trial.

2

Dysglycaemia and risk of cardiovascular disease.

Gerstein HC, Yusuf S. Gerstein HC, et al. Among authors: yusuf s. Lancet. 1996 Apr 6;347(9006):949-50. doi: 10.1016/s0140-6736(96)91420-8. Lancet. 1996. PMID: 8598762 No abstract available.

3

Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review.

Teo KK, Yusuf S, Pfeffer M, Torp-Pedersen C, Kober L, Hall A, Pogue J, Latini R, Collins R; ACE Inhibitors Collaborative Group. Teo KK, et al. Among authors: yusuf s. Lancet. 2002 Oct 5;360(9339):1037-43. doi: 10.1016/s0140-6736(02)11138-x. Lancet. 2002. PMID: 12383982 Review.

4

Relationship of anti-60 kDa heat shock protein and anti-cholesterol antibodies to cardiovascular events.

Veres A, Füst G, Smieja M, McQueen M, Horváth A, Yi Q, Bíró A, Pogue J, Romics L, Karádi I, Singh M, Gnarpe J, Prohászka Z, Yusuf S; Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Veres A, et al. Among authors: yusuf s. Circulation. 2002 Nov 26;106(22):2775-80. doi: 10.1161/01.cir.0000038890.39298.8d. Circulation. 2002. PMID: 12451002

5

The relationship between dysglycemia and atherosclerosis in South Asian, Chinese, and European individuals in Canada: a randomly sampled cross-sectional study.

Gerstein HC, Anand S, Yi QL, Vuksan V, Lonn E, Teo K, Malmberg K, McQueen M, Yusuf S; SHARE Investigators. Gerstein HC, et al. Among authors: yusuf s. Diabetes Care. 2003 Jan;26(1):144-9. doi: 10.2337/diacare.26.1.144. Diabetes Care. 2003. PMID: 12502671

6

Preventing stroke with ramipril--authors' reply.

Yusuf S, Bosch J, Sleight P. Yusuf S, et al. BMJ. 2003 Jan 4;326(7379):52. doi: 10.1136/bmj.326.7379.52. BMJ. 2003. PMID: 12511474 Free PMC article. No abstract available.

7

Multiple infections and subsequent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.

Smieja M, Gnarpe J, Lonn E, Gnarpe H, Olsson G, Yi Q, Dzavik V, McQueen M, Yusuf S; Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Smieja M, et al. Among authors: yusuf s. Circulation. 2003 Jan 21;107(2):251-7. doi: 10.1161/01.cir.0000044940.65226.1f. Circulation. 2003. PMID: 12538424

8

Diagnostic strategies to detect glucose intolerance in a multiethnic population.

Anand SS, Razak F, Vuksan V, Gerstein HC, Malmberg K, Yi Q, Teo KK, Yusuf S. Anand SS, et al. Among authors: yusuf s. Diabetes Care. 2003 Feb;26(2):290-6. doi: 10.2337/diacare.26.2.290. Diabetes Care. 2003. PMID: 12547851

9

Development of renal disease in people at high cardiovascular risk: results of the HOPE randomized study.

Mann JF, Gerstein HC, Yi QL, Lonn EM, Hoogwerf BJ, Rashkow A, Yusuf S. Mann JF, et al. Among authors: yusuf s. J Am Soc Nephrol. 2003 Mar;14(3):641-7. doi: 10.1097/01.asn.0000051594.21922.99. J Am Soc Nephrol. 2003. PMID: 12595499 Clinical Trial.

10

Cost implications of the use of ramipril in high-risk patients based on the Heart Outcomes Prevention Evaluation (HOPE) study.

Lamy A, Yusuf S, Pogue J, Gafni A; Heart Outcomes Prevention Evaluation Investigators. Lamy A, et al. Among authors: yusuf s. Circulation. 2003 Feb 25;107(7):960-5. doi: 10.1161/01.cir.0000050600.49419.25. Circulation. 2003. PMID: 12600907

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,965 results

Search Page